The effects of estrogen replacement therapy on the risk of cancer during the post-menopausal years
Publisher
Springer Netherlands
Reference30 articles.
1. Bergsjö, P. (1965). Progesterone—progestational compounds in the treatment of advanced endometrial carcinoma. Acta Endocrinol., 49, 412
2. Hustin, J. (1970). Endometrial carcinoma and synthetic progestogens; results of intra-uterine treatment. J. Obst. Gynaecol. Brit. Cmnwlth., 77, 915
3. John, A. H., Cornes, J. S., Jackson, W. D. and Bye, P. (1974). Effect of a systemically administered progestogen on histopathology of endometrial carcinoma. J. Obst. Gynaecol. Br. Cmnwlth., 81, 786
4. McCarroll, A. M., Montgomery, D. A. D., Harley, J. G., McKeown, E. F. and MacHenry, J. C. (1975). Endometrial carcinoma of the cyclical oestrogen-progestogen therapy for Turner’s Syndrome. Brit. J. Obst. Gynaecol., 82, 421
5. Gusberg, S. B. (1947). Precursors of corpus carcinoma: estrogens and adenomatous hyperplasia. Am. J. Obstet. Gynecol., 54, 905